340B Drug Pricing Program
The Supreme Court of the United States today ruled unanimously in favor of the AHA and others, reversing a 2020 court of appeals decision upholding the authority of the Department of Health and Human Services to significantly cut payments to certain hospitals that participate in the 340B Drug…
Tax-exempt hospitals are required to publicly report on the ways in which they improve the health of the communities they serve yearly through the IRS Form 990 Schedule H, which is publicly available. In 2019, the most recent year for which this information is available, tax-exempt hospitals…
The AHA and other hospital groups urged the courts to require drug companies to fulfill their legal obligations.
The AHA, 340B Health, America’s Essential Hospitals, Association of American Medical Colleges, and Children’s Hospital Association yesterday urged the U.S. Courts of Appeals for the 3rd and District of Columbia Circuits to require drug companies to fulfill their legal obligations to provide 340B…
The Health Resources and Services Administration late last week told Merck that it must immediately begin offering its covered outpatient drugs at the 340B ceiling price to covered entities through their contract pharmacy arrangements, regardless of whether they purchase through an in-house…
Reminder: Deadline is April 29 to Submit Information to AHA.
We recently sent you a note asking for your help completing a form that will help with our advocacy efforts to push back against illegal actions several drug manufacturers are taking to limit 340B pricing to contract pharmacies. Thank you to those organizations that already have completed the form.
President Biden today submitted to Congress his budget request for fiscal year (FY) 2023.
AHA shares proposals to lower Medicare drug prices with congress.
The Senate last night passed a $1.5 trillion omnibus appropriations bill that would fund the federal government through the end of the current fiscal year.